Scientists Identify Key Cellular Targets for Broad-Spectrum Antiviral Defense
A new study reveals a promising strategy for combating not just teh common cold, but a wide range of viruses, including those responsible for severe illnesses like COVID-19. Researchers at the Pacific Northwest National Laboratory (PNNL) have pinpointed crucial molecular control points within human cells that viruses exploit to replicate, opening the door to potential therapies that bolster the bodyS natural defenses.
scientists have long sought to understand how viruses establish themselves within the body,and this research identifies key cellular checkpoints that are vital targets. The findings, published in the Journal of Proteome Research, detail a method for fortifying these cellular components-to stop viruses before they have a chance to take over the cell.
This approach,according to a leading virologist on the project,offers a novel way to combat coronaviruses ranging from those causing mild cold symptoms to those responsible for severe diseases like COVID-19 and acute respiratory distress syndrome (ARDS). “This approach offers a pathway for using a single drug to stop multiple types of viruses,” she stated. “When you target only the virus, it can produce strains that readily escape antiviral medications. But by targeting key functions in the host cell that the virus needs to replicate, and by turning off those host functions, we hope to eliminate the escape route most viruses use to cause disease.”
The researchers employed a cutting-edge technique called limited proteolysis-based mass spectrometry (LiP-MS) to analyze human cells infected with HCoV-229E,a common cold virus. LiP-MS doesn’t just measure the amount of proteins present, but also detects changes in their shape – a critical factor determining their function and interactions.
The team identified eight viral targets, with a particular focus on two molecular assemblies vital for RNA processing. In both instances, the virus commandeers normal cellular functions to replicate itself. By blocking the virus’s interaction with these assemblies,the researchers significantly reduced its ability to thrive in human lung cells.
Specifically, the virus targets Nop-56, a molecule responsible for “stamping” RNA strands as legitimate. This approval allows ribosomes to produce proteins from the RNA. When hijacked, the virus destroys human RNA, halting normal protein production and rather approving the creation of viral proteins. Another key target is the spliceosome C-complex, which edits RNA by removing non-essential regions. Viral takeover of this complex diverts the cell from producing its own proteins, prioritizing viral protein synthesis.
To illustrate the concept, researchers drew an analogy to a drone factory taken over by an enemy. “Picture a drone factory in a country at war, turning out products to defend itself. Imagine that a foreign invader takes over the factory, halts production and then uses the factory to turn out its own drones that are used to attack the home country. That’s similar to what happens when a virus invades a person.”
The research team, led by a postdoctoral fellow and first author of the paper, believes their work will lay the groundwork for developing drugs capable of blocking a wide range of disease-causing viruses. “we hope our work provides a list of common molecular targets that sets the foundation for the development of drugs that could block not just one but many viruses that cause disease,” she said. “Viruses can mutate quickly, and that poses a problem when targeting a virus directly. that obstacle is removed if you target proteins that many viruses rely upon in the host.”
Currently, the PNNL team is investigating existing compounds identified by scientists at Oregon Health & Science University as having antiviral potential. They are also leveraging artificial intelligence to rapidly identify new compounds that could disrupt the identified molecular targets. this multi-pronged approach signals a promising new era in antiviral research, one focused on empowering the body to fight off viral threats before they can take hold.
More facts: Snigdha Sarkar et al, Human Coronavirus-229E Hijacks Key Host-Cell RNA-Processing Complexes for Replication, Journal of Proteome Research (2025).DOI: 10.1021/acs.jproteome.5c00400
